Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Elastic Sealant Protects Suture Line After Gastro Surgery

By HospiMedica International staff writers
Posted on 30 Aug 2015
A novel synthetic sealant has been specifically designed to help reduce leaks after gastrointestinal (GI) anastomosis procedures. More...


Sylys Surgical Sealant helps reduce anastomotic leakage in GI procedures by providing additional support to the anastomosis during the first few days of healing, when the development of leaks is most likely to occur. The elastic, resorbable, synthetic sealant protects the suture or staple line used in standard anastomotic closure techniques, supporting the anastomosis during the first few days of healing when leaks are most likely to occur. The rapid curing, single-part sealant provides good adherence to tissue, creating a flexible, elastic seal over the anastomosis site.

The curing process is initiated by contact of the viscous fluid with the moisture in the tissue. The cured sealant forms a network of large polymeric chains that allows it to remain soft and flexible, while also creating a strong tissue bond. The sealant remains well adhered to the tissue during the first two weeks after surgery, and then proceeds to break down into harmless subcomponents over a period of three months. Burst strength testing of the product shows that it is able to withstand pressures over 150 mmHg, twice that of normal bowel peristalsis. Sylys Surgical Sealant is a product of Cohera Medical (Pittsburg, PA, USA), and has received the European Community CE marking of approval.

“Sylys enhances standard closure techniques, advancing the healing process and reducing postoperative complications,” said Patrick Daly, President and CEO of Cohera Medical. “We are a step closer to providing patients with the best opportunity for a successful outcome following intestinal anastomosis procedures.”

“Anastomotic leak is the most devastating complication associated with intestinal resection, contributing to morbidity and mortality,” said James McCormick, DO, program director for general surgery at Forbes Hospital (Monroeville, PA, USA). “We have made tremendous strides in curtailing the risk associated with intestinal anastomosis, but we are always striving for further improvement and greater patient safety.”

Anastomotic leakage rates following colon resection range on average from 3%–15%. Such leakage is considered the most serious complication of bowel repair, doubling the length of stay and increasing mortality rates as much as ten-fold, with at least one third of the post-surgical mortality after colorectal surgery is attributed to leaks. Beyond the initial mortality risk, reoperation rates after leakage can be as high as 87%, and overall five year survival rates are reduced by 20%.

Related Links:

Cohera Medical



Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Emergency Ventilator
Shangrila935
Radiation Safety Barrier
RayShield Intensi-Barrier
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.